Molex Incorporated (NASDAQ: MOLX)(NASDAQ: MOLXA) today announced it has been honored as a supplier to a winning product, the NeuroStar TMS Therapy� system by Neuronetics Incorporated, in the 2009 Medical Design Excellence Awards (MDEA) competition, the premier awards program for the medical technology community. The MDEA will present the award on June 10 at the Medical Design & Manufacturing East 2009 Conference and Exposition in New York City.

�We are honored that Neuronetics chose us as a supplier for its system and extremely pleased to be selected for this prestigious award. Over the past four years, Molex has worked with Neuronetics to improve and perfect the SenStar� Treatment Link assembly for patient comfort and effectiveness,� said Justin Spitzer, business development manager, Molex Incorporated. �This has culminated in the NeuroStar TMS Therapy system being recently cleared by the U.S. Food and Drug Administration for the treatment of major depressive disorder in adult patients who have failed to achieve satisfactory improvement from prior antidepressant medication.�

The NeuroStar TMS Therapy system is an electromagnetic medical device for the treatment of major depressive disorder. It operates by applying a focused, pulsed magnetic field that inductively stimulates cortical neurons associated with depression.

The patented SenStar, supplied by Molex, is an integrated flexible switch and circuit assembly which includes an x-y position sensing, non-tactile membrane switch and a flexible circuit. The switch portion provides feedback for proper positioning of the Neurostar Treatment Coil while the flexible circuit reduces scalp sensation during treatment.

Learn more about the 2009 Medical Design Excellence Awards at http://www.devicelink.com/expo/awards/awards/index.php.

About Molex Incorporated

Molex Incorporated is a 70-year-old global manufacturer of electronic, electrical and fiber optic interconnection systems. Based in Lisle, Illinois, USA, the company operates 45 manufacturing locations in 17 countries. The Molex website is www.molex.com.

About Molex User Interface Technology

Molex Incorporated is one of the world�s largest suppliers of tactile and non-tactile membrane switches, LED and LCD display assemblies, flexible circuits, dome arrays and control panel assemblies, with global manufacturing capabilities. For additional information on Molex�s user interface technology offering, please visit: www.molex.com/product/switch.

Molex� is a registered trademark of Molex Incorporated.

NeuroStar TMS Therapy� and SenStar� are registered trademarks of Neuronetics Incorporated.

Molex Incorporated (MM) (NASDAQ:MOLX)
Historical Stock Chart
Von Jun 2024 bis Jul 2024 Click Here for more Molex Incorporated (MM) Charts.
Molex Incorporated (MM) (NASDAQ:MOLX)
Historical Stock Chart
Von Jul 2023 bis Jul 2024 Click Here for more Molex Incorporated (MM) Charts.